Skip to main content
WELL Health Technologies Corp. logo

WELL Health Technologies Corp. — Investor Relations & Filings

Ticker · WELL ISIN · CA94947L1022 LEI · 254900HK2IQLCK4I7B82 TSX Human health and social work activities
Open in API
Filings indexed 616 across all filing types
Latest filing 2024-08-14 Regulatory Filings
Country CA Canada
Listing TSX WELL

About WELL Health Technologies Corp.

https://well.company/

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company dedicated to modernizing healthcare delivery and positively impacting health outcomes globally. The company operates a comprehensive, synergistic ecosystem across Canada and the United States. Its operations are structured into two main segments: Omni-Channel Patient Services and Virtual Services. Omni-Channel Patient Services includes being Canada's largest owner and operator of outpatient medical clinics, providing primary, specialized, and diagnostic care, complemented by US telehealth, clinic operations, and anesthesia services. Virtual Services are delivered through the Practitioner Enablement Platform, offering a suite of digital tools to over 42,000 healthcare providers. These tools include Electronic Medical Records (EMR), virtual care, Revenue Cycle Management (RCM), AI solutions, and patient engagement systems designed to streamline administrative tasks and enhance care delivery efficiency.

Recent filings

Filing Released Lang Actions
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CEO of WELL Health Technologies Corp. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2024. The content is primarily an officer certification regarding the interim filings, controls, and procedures, without containing actual financial statements or substantive financial data. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3411 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2024-08-14 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM MANAGEMENT’S DISCUSSION AND ANALYSIS FOR THE SIX MONTHS ENDED JUNE 30, 2024' and contains detailed discussion and analysis of the company's financial and operational performance for the six-month interim period ending June 30, 2024. It references condensed interim consolidated financial statements and includes non-GAAP financial measures, business segment descriptions, and key metrics for the interim period. The content is consistent with an Interim / Quarterly Report, which provides comprehensive financial data and management analysis for a period shorter than a full fiscal year. The document length is substantial (15,000 characters), indicating it is the report itself rather than an announcement. Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). H1 2024
2024-08-14 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for WELL Health Technologies Corp. as of June 30, 2024. It contains detailed financial statements including statements of income, financial position, changes in equity, and cash flows, all marked as unaudited and interim. The presence of financial data for a six-month period ending June 30, 2024, and the term 'interim' clearly indicate this is a quarterly or half-year financial report. The document is lengthy (15,000 characters) and contains substantive financial data, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-14 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a corporate update press release from WELL Health Technologies Corp. about its majority-owned subsidiary Circle Medical surpassing a $100M USD revenue run rate and maintaining profitability. It includes financial highlights such as revenue figures, growth rates, profitability on an adjusted EBITDA basis, and strategic initiatives including leadership hires and AI partnerships. The document also mentions that WELL Health will discuss these results in its upcoming quarterly earnings call. However, the document does not contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is a standalone corporate update focusing on financial performance and strategic positioning, which aligns best with a Capital/Financing Update (CAP) as it discusses financial performance milestones and strategic options including retaining JP Morgan as financial advisor to explore growth options. The document length (8585 characters) and content indicate it is more than a brief announcement but does not constitute a full financial report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-08-13 English
News release - English.pdf
Regulatory Filings
2024-07-30 English
News release - English.pdf
Regulatory Filings
2024-07-17 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.